Deadline: 26-Aug-2026
The Gustave Roussy Prize recognizes outstanding contributions to oncology research that have significantly advanced cancer diagnosis, treatment, or prevention. The award highlights scientific innovation with measurable and lasting benefits for patient care worldwide.
The prize is an annual international distinction awarded by the Gustave Roussy Foundation with support from Pierre Fabre as the founding sponsor. It is endowed with €200,000, including €100,000 for the laureate’s unrestricted personal use and €100,000 to support an innovative oncology research project.
What is the Gustave Roussy Prize?
The Gustave Roussy Prize is an international oncology research award that recognizes major scientific contributions in cancer research.
The prize honours researchers whose work has led to meaningful progress in cancer diagnosis, treatment, prevention, or patient care.
It is awarded annually by the Gustave Roussy Foundation and supported by Pierre Fabre as the founding sponsor.
Main Purpose of the Prize
The main purpose of the Gustave Roussy Prize is to celebrate transformative oncology research that improves outcomes for patients.
The award focuses on scientific excellence, clinical impact, and innovation that changes how cancer is understood, diagnosed, treated, or prevented.
It aims to recognize research that has produced measurable and lasting benefits for cancer patients worldwide.
Focus Areas and Priorities
The prize focuses on high-impact oncology research.
Key focus areas include:
- Cancer research
- Oncology innovation
- Cancer diagnosis
- Cancer treatment
- Cancer prevention
- Therapeutic strategies
- Preventive strategies
- Patient care improvement
- Clinical impact
- Scientific excellence
- Translational oncology
- Global cancer care
- Patient outcomes
Key Concepts Explained
Oncology Research
Oncology research is the scientific study of cancer.
It includes research into cancer biology, diagnosis, treatment, prevention, disease progression, therapeutic innovation, clinical care, and patient outcomes.
Cancer Diagnosis
Cancer diagnosis refers to methods used to detect and identify cancer.
Research in this area may improve early detection, accuracy, screening methods, biomarkers, imaging, pathology, or diagnostic technologies.
Cancer Treatment
Cancer treatment research focuses on therapies that prevent, control, or eliminate cancer.
This may include drug development, immunotherapy, targeted therapy, radiotherapy, surgery, precision medicine, combination treatments, or new therapeutic approaches.
Cancer Prevention
Cancer prevention research aims to reduce the risk of cancer development.
This may include work on lifestyle factors, vaccines, screening, genetic risk, environmental exposure, early intervention, or public health strategies.
Clinical Impact
Clinical impact means that the research has improved or can improve real-world patient care.
This may include better survival, improved quality of life, fewer side effects, earlier diagnosis, more effective therapies, or stronger prevention strategies.
Award Amount
The Gustave Roussy Prize is endowed with a total of €200,000.
The funding is divided into two parts:
- €100,000 for the laureate’s unrestricted personal use
- €100,000 to support an innovative oncology research project
This structure recognizes both the researcher’s achievements and their continued contribution to cancer research.
Award Presentation Date
The prize will be presented on February 4, 2027.
This date coincides with World Cancer Day, highlighting the global importance of cancer research, prevention, treatment, and patient care.
The timing reinforces the award’s international relevance and its connection to worldwide efforts to improve cancer outcomes.
Who is Eligible?
Researchers of all nationalities are eligible to apply.
Eligibility is open regardless of institutional affiliation.
The prize is intended for researchers whose work demonstrates outstanding scientific excellence and meaningful clinical impact in oncology.
Eligible applicants may include researchers working in:
- Universities
- Hospitals
- Cancer research centres
- Medical research institutions
- Public research organisations
- Private research institutions
- International research environments
Selection Criteria
Selection is based strictly on scientific excellence and clinical impact.
Applications are assessed by an independent international jury of experts.
Key selection factors may include:
- Originality of the research
- Importance of the scientific contribution
- Impact on cancer diagnosis, treatment, or prevention
- Benefits for patient care
- Strength of evidence
- International relevance
- Innovation in oncology
- Long-term contribution to cancer research
How the Prize Works
The Gustave Roussy Prize recognizes a researcher whose work has made a major contribution to oncology.
Applicants are assessed by an independent international jury.
The selected laureate receives the prize funding and is honoured during the award presentation on February 4, 2027.
Part of the award is available for unrestricted personal use, while the other part supports a future innovative oncology research project.
How to Apply
Applicants should prepare a strong nomination or application that clearly presents their contribution to oncology research.
The application should explain how the research has advanced cancer diagnosis, treatment, prevention, or patient care.
Applicants should highlight the scientific innovation, evidence of impact, and patient benefit associated with the work.
They should also clearly explain how the research has contributed to measurable and lasting improvements in oncology.
Suggested Application Steps
- Confirm that the applicant is a researcher with significant contributions to oncology.
- Identify the main research achievement being submitted for consideration.
- Explain how the work advances cancer diagnosis, treatment, or prevention.
- Describe the clinical impact and patient care benefits.
- Highlight scientific innovation and originality.
- Provide evidence of measurable and lasting impact.
- Explain the global or international relevance of the research.
- Prepare details of the innovative oncology research project that could be supported by the project funding.
- Submit the application through the official prize process.
Why It Matters
Cancer remains a major global health challenge, and progress depends on strong scientific research.
The Gustave Roussy Prize matters because it recognizes researchers whose discoveries improve how cancer is diagnosed, treated, prevented, or managed.
By supporting both the laureate and a future research project, the prize helps advance innovation in oncology and encourages continued progress in patient care.
The award also reinforces the importance of translating scientific discoveries into real benefits for patients worldwide.
Common Mistakes to Avoid
Applicants should avoid focusing only on academic prestige without clearly explaining patient impact.
Applications should not present research achievements without evidence of scientific excellence.
Applicants should avoid vague claims about innovation or impact.
The application should clearly connect the research to cancer diagnosis, treatment, prevention, or patient care.
Applicants should not overlook the importance of measurable and lasting patient benefits.
They should also avoid submitting incomplete or unclear descriptions of the research contribution.
Tips for Strong Applications
A strong application should clearly describe the research breakthrough and why it matters in oncology.
Applicants should explain how the work has changed understanding, diagnosis, treatment, prevention, or care.
The application should include evidence of patient benefit, clinical relevance, or real-world impact.
Applicants should highlight the originality and international importance of the research.
The proposed oncology research project supported by the prize funding should be innovative, relevant, and aligned with the broader goal of improving patient outcomes.
Frequently Asked Questions
1. What is the Gustave Roussy Prize?
The Gustave Roussy Prize is an annual international award that recognizes outstanding contributions to oncology research with meaningful impact on cancer diagnosis, treatment, prevention, and patient care.
2. Who awards the prize?
The prize is awarded by the Gustave Roussy Foundation with support from Pierre Fabre as the founding sponsor.
3. How much funding does the prize provide?
The prize is endowed with €200,000 in total.
4. How is the prize funding divided?
€100,000 is granted for the laureate’s unrestricted personal use, and €100,000 is allocated to support an innovative oncology research project.
5. Who can apply?
Researchers of all nationalities and institutional affiliations are eligible to apply.
6. What are the main selection criteria?
Selection is based on scientific excellence and clinical impact, as assessed by an independent international jury of experts.
7. When will the prize be presented?
The prize will be presented on February 4, 2027, coinciding with World Cancer Day.
Conclusion
The Gustave Roussy Prize is a major international distinction for researchers whose work has advanced oncology and improved cancer care.
With a total endowment of €200,000, the prize recognizes both past achievement and future innovation in cancer research.
Applicants should clearly demonstrate scientific excellence, clinical impact, measurable patient benefit, and a strong contribution to cancer diagnosis, treatment, or prevention.
For more information, visit Gustave Roussy.
